Anzeige
Mehr »
Login
Dienstag, 19.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Solarbetriebenes Krypto-Mining: Die Strategie, die diese Aktie um 75?% steigen ließ!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
737 Leser
Artikel bewerten:
(2)

BIO KOREA Organizing Committee: BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022

Finanznachrichten News

Global Event to Kick off as the Post-COVID Era Begins in Earnest, with Theme "Beyond the Pandemic, into a Next Wave"

SEOUL, South Korea, April 7, 2022 /PRNewswire/ --Initiated in 2006, BIO KOREA is the biggest bio-health convention in Asia that is dedicated to promoting the international standing of Korea's healthcare industry and ensuring the industry's sustainable growth. BIO KOREA 2022 will take place in COEX, Seoul from Wednesday, May 11 to Friday, May 13, 2022.

In 2021, the international convention faced a challenge of organizing an online-offline hybrid event amidst the pandemic, but against the odds it galvanized its reputation as Korea's leading international bio-health convention, attracting 7,000 participants from 800 companies and organizations in 69 countries. With high hopes for the post-COVID era in 2022, this year's convention is organized under the banner of "Beyond the Pandemic, into the Next Wave." The programs are centered around businesses in the bio-health industry, for example post-COVID, digital healthcare, and up-to-the-minute therapeutic technologies.

With the presence of some of the world's brightest minds, investors, executives, business experts, and researchers, BIO KOREA 2022 will offer important business and global partnership opportunities through business forums, exhibition, conference, and investment fair.

The exhibition showcases the latest healthcare technologies and products with a range of demonstrations. Companies and institutions in the healthcare industry and many embassies set up national pavilions, where stellar businesses will participate as exhibitors. Particularly noticeable is the Metaverse Zone, where some of the most eye-catching future technologies will be demonstrated. Visitors will have opportunities to eyewitness the future of the global bio-health industry and have firsthand experience in the latest technologies.

Another key program, the business forum consists of Partnering and BIO LIVE. Designed to discover potential partnership opportunities and promote technologies and products, the forum also offers 1:1 meeting opportunities to discuss business and research cooperation and networking. The Partnering Center was open on the BIO KOREA 2022 official website (www.biokorea.org) on March 2, where metaverse companies, vaccine ingredients and diagnostic technology exhibitors that are attracting strong attention in Korea, promising startups, clinical trial labs, pharmaceutical companies, and research institutions are looking for business partners. Facing soaring requests globally, the convention organizer plans to run the online and offline Partnering Center 24/7 to maximize global partnership opportunities. Designed for business matching, BIO LIVE aims at bidirectional connections between online and offline participants for public relations and business matching.

The conference offers seminars themed around various topics including technology licensing, bio intellectual properties, medical devices, and pharmaceuticals, where internationally renowned scholars and experts will share their insights with participants and discuss the latest technological developments. Key topics to be covered include vaccines, immunotherapies for cancer, microbiome, Alzheimer's, and regenerative medicine, the sessions are well-organized into major tracks such as digital health and technological business to keep up with the latest developments and best practices and discuss future prospects in bio-health.

The investment fair will serve as a stepping stone for pharmaceutical, bio, and healthcare companies to advance into global markets, where they will showcase their drug development pipelines, advanced technologies, visions, and strategies.

BIO KOREA forms part of the development of the nation's bio-health industry. This year, the international convention is set to further solidify its position as Korea's leading bio-health convention by providing a forum to share intelligence on the global bio-health market and trade innovative future technologies to take the lead in the global market.

For more information about Bio Korea 2022, please visit our website. https://www.biokorea.org/index.asp?pLn=Eng or https://www.youtube.com/watch?v=4oVP6waOc7Y

BIO KOREA Organizing Committee
+82-1661-0810
biokorea@biokorea.org

Photo - https://mma.prnewswire.com/media/1779513/Bio_Korea_2022_Poster.jpg

© 2022 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.